Vaccine News and Research

Latest Vaccine News and Research

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

In a recent research article published in the journal of Science Immunology, a team of researchers from Japan performed longitudinal analysis on the cellular composition of receptor-binding domain (RBD) memory B cell subsets and its antibody binding and neutralizing activity against the Beta, Delta, and Omicron variants following the second dose of a messenger ribonucleic acid (mRNA) vaccine.

8 Feb 2022

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

In a recent research paper published in the journal Infection, the scientists estimated the transmission and disease severity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant and the effectiveness of the current coronavirus disease 2019 (COVID-19) vaccines against the same by conducting a literature review. Further, a meta-analysis was conducted to obtain a numeric estimate of the vaccine effectiveness against the Delta variant.

7 Feb 2022

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies against SARS-CoV-2.

7 Feb 2022

mRNA-based COVID-19 booster vaccination shown to protect against severe omicron infection in macaques

Scientists recently evaluated the effectiveness of a booster dose of the Moderna-developed COVID-19 vaccine and omicron spike-specific mRNA vaccine in non-human primates that are primed with the Moderna vaccine.

7 Feb 2022

Study explores omicron-reactive T- and B- cell responses in COVID-19 vaccine recipients

A new study analyzes neutralizing antibodies and T-cell responses targeting the SARS-CoV-2 D614G, as well as some variants of concern.

7 Feb 2022

Evaluating delayed vaccination schedules for protection against SARS-CoV-2

Researchers conducted an observational study to compare the humoral and cellular responses in health care workers who had received two doses of the Pfizer-BioNTech vaccine at standard (3 to 6 weeks) and delayed (8 to 16 week) intervals.

7 Feb 2022

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

In a recent study published in the latest issue of the journal Cell, a team of researchers evaluated T-cell reactivity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant's spike (S) and non-spike proteins.

6 Feb 2022

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

A recent study posted to the Research Square* preprint server and under consideration for inclusion in the journal Scientific Reports assessed the epidemiology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfections.

6 Feb 2022

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic's impact on women and sexual and gender minorities.

6 Feb 2022

Researchers discover a new function of anti-HIV-1 antibodies

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures.

6 Feb 2022

A novel approach to predict mutations within the SARS-CoV-2 spike

A study posted recently to the bioRxiv* preprint server demonstrated that the emergence of new spike variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can be predicted.

6 Feb 2022

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

The first published case describing the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a domestic cat in the United States highlights the realistic scenario of spillover infections with emerging viral variants that threaten human and animal health.

6 Feb 2022

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Researchers assess the understanding and trust of the revised COVID-19 isolation and quarantine guidance recommended by the U.S. CDC.

6 Feb 2022

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Researchers discuss the impact of mRNA booster immunization on the neutralizing activity against the SARS-CoV-2 Omicron variant in the elderly.

6 Feb 2022

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Within only three weeks after the omicron variant was first identified among Houston Methodist patients, this variant rapidly took over and became the cause of a majority of new cases.

4 Feb 2022

Using interdisciplinary approach to beat cancer

European Cooperation in Science and Technology (COST) World Cancer Day aims at raising awareness of cancer and to encourage its prevention, detection, and treatment.

4 Feb 2022

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

If close friends and family members who contracted COVID-19 had mild cases and recovered quickly, or if they had an adverse reaction to the vaccine, your brain might convince you that you'd have the same experience.

4 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

Younger mothers have the least intention to vaccinate children for COVID-19

Fathers older than age 34 were more open to having their child vaccinated against COVID-19, while younger Black and white mothers were the least open to it, finds a new survey of Medicaid recipients from the Brown School at Washington University in St. Louis.

4 Feb 2022

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Scientists recently assessed the immunogenicity of a third booster dose of COVID-19 vaccines against SARS-CoV-2 variants.

4 Feb 2022

Vaccine News and Research

Latest Vaccine News and Research

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

mRNA-based COVID-19 booster vaccination shown to protect against severe omicron infection in macaques

Study explores omicron-reactive T- and B- cell responses in COVID-19 vaccine recipients

Evaluating delayed vaccination schedules for protection against SARS-CoV-2

Booster vaccines found to augment T-cell responses to SARS-CoV-2 Omicron

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

Northwestern researchers study COVID-19 mechanisms, infection patterns and impact on gender minorities

Researchers discover a new function of anti-HIV-1 antibodies

A novel approach to predict mutations within the SARS-CoV-2 spike

Detection of SARS-CoV-2 Delta variant infection in a domestic cat

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

Booster dose of Pfizer-BioNTech COVID vaccine protects elderly against Omicron

Study finds increased vaccine breakthrough, less hospitalization rates and disease severity in omicron patients

Using interdisciplinary approach to beat cancer

Cognitive shortcuts may promote unsafe behaviors during the COVID-19 pandemic

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Younger mothers have the least intention to vaccinate children for COVID-19

mRNA booster vaccination shown to induce robust neutralizing antibodies against SARS-CoV-2 omicron variant

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in